Fuzeon (Enfuvirtide, T-20)

The Basics | News | Research | First Person

See also: Medication Side Effects | Drug Interactions | All HIV Medications

Brand Name:	Fuzeon
Generic Name:	Enfuvirtide, T-20
Adult Single Dose:	Patients weighing more than 94 lbs (42.6 kg): 90 mg (1 mL) injected subcutaneously into the upper arm, thigh, or abdomen (twice a day)
Food & Liquid Restrictions:	None
Drug Class:	FI

From The Body's "Ask the Experts" Forums

Is it possible to stay on Fuzeon and not become resistant?
My doctor wants me to start Fuzeon only for 6 months then stop once my VL hopefully becomes undetectable. I am told this is a new and somewhat experimental approach, which sounds good in theory, but I am worried about resistance developing. Should I save Fuzeon for later?

» More questions

The Basics

Enfuvirtide (Fuzeon) (April 18, 2012)
To read PDF, click here.
From AIDS InfoNet
Fuzeon (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
An Overview of Fuzeon (Enfuvirtide, T-20) (October 10, 2011)
From AIDSinfo
Fuzeon (Enfuvirtide, T-20) Patient Product Information (PDF) (April 2011)
From Roche
Patient Information About Fuzeon (Enfuvirtide, T-20) (PDF) (April 2011)
From Roche
Fuzeon Injection Instructions (PDF) (2010)
From Genentech USA, Inc., and Trimeris, Inc.
Fuzeon (Enfuvirtide, T-20) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Important Changes to Fuzeon Product Labeling (January 31, 2007)
From U.S. Food and Drug Administration
T-20 (Enfuvirtide, Fuzeon) (August 15, 2006)
From AIDS Treatment Data Network
Fuzeon (Enfuvirtide) (May 2005)
[Archived Article]
To read PDF, click here.
From The Center for AIDS
A Guide to Fuzeon: The First Fusion Inhibitor (January 2005)
[Archived Article]
To read PDF, click here.
In A Guide to Fuzeon: The First Fusion Inhibitor, from TheBody.com
Transcript of The Body's Live Chat on Fuzeon (T-20, Enfuvirtide) (October 25, 2004)
From TheBody.com
Drug Interactions: Enfuvirtide (August 2004)
[Archived Article]
From Project Inform
Transcript of The Body's Live Chat on Fuzeon (T-20, Enfuvirtide) (June 16, 2004)
From TheBody.com
Treatment Forum Discusses T-20 (January/February 2004)
[Archived Article]
Answers questions such as: Why is T-20 so expensive? Can it be taken by itself, or does it always have to be part of a combination? What about side effects?.
In Survival News, from AIDS Survival Project
Three New Drugs Approved by FDA (November/December 2003)
[Archived Article]
An overview of Fuzeon (enfuvirtide, T-20), Reyataz (atazanavir) and Emtriva (emtricitabine, FTC).
In Survival News, from AIDS Survival Project
The Essential Facts About Injections (October 2003)
From TheBody.com
Ten Tips on Injecting Fuzeon (October 2003)
In Fuzeon: A Review of the First Entry Inhibitor, from TheBody.com
Fuzeon: A Review of the First Entry Inhibitor (October 2003)
A look at how entry inhibitors and Fuzeon work.
To read PDF, click here.
From TheBody.com
The Bottom Line on T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
[Archived Article]
Bare-bones highlights of three of this year's new HIV medications.
To read PDF, click here.
In Project Inform Perspective, from Project Inform
From Injections to Pricing: The Drawbacks of T-20 (April 2003)
[Archived Article]
In TAGline, from Treatment Action Group
Fuzeon (T-20) Approved in the U.S. (March 13, 2003)
[Archived Article]
First drug in a new class of HIV/AIDS treatments for HIV-infected adults and children with advanced HIV infection.
From U.S. Food and Drug Administration
New AIDS Drug Price Spurs Some Questions (March 13, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Long Path to Approval (March 2003)
[Archived Article]
A look back at Fuzeon's road from laboratory to pharmacy.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Entry Inhibitors: T-20 (Winter 2002/2003)
[Archived Article]
In ACRIA Update, from AIDS Community Research Initiative of America
What's Taking T-20 So Long? (April 2001)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis

First Person

FAQs About Fuzeon (Enfuvirtide) (February 28, 2012)
From The Body's "Ask the Experts" Forums
Profiles in Courage: Reverend Frederick Batiste (April 8, 2007)
From TheBody.com
Rob From Los Angeles: A Fuzeon Veteran (2007)
From TheBody.com
Greg Braxton: A Long Journey to Recovery (January 2005)
With a 27-year history of drinking, using drugs and sleeping with hundreds of women, Greg Braxton's AIDS diagnosis in 1994 came as no surprise.
In A Guide to Fuzeon: The First Fusion Inhibitor, from TheBody.com
Beatriz Diaz: From Silence to Success (January 2005)
Beatriz Diaz, 49, learned the hard way that loving yourself is critical to committing to HIV treatment.
In A Guide to Fuzeon: The First Fusion Inhibitor, from TheBody.com
Positive Empowerment: I Get Blessings, I Get Lesson (July/August 2003)
[Archived Article]
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
The Constant Survival Battle and T-20 (Winter 2002/2003)
All of Matt Sharp's other meds had failed; then it was T-20's turn.
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
A T-20 Diary (March 2002)
Fred Gormley's first few days as part of the drug's clinical trial.
In GMHC Treatment Issues, from Gay Men's Health Crisis